Heart Rhythm 2008 features the world's leading experts and the most rigorous scientific research on the subjects that matter most to cardiac arrhythmia professionals.

Building upon the success of last year's sold-out AF Summit at Heart Rhythm 2007, this year's AF Summit Update, held on Thursday, May 15, Moscone Center Room 103, consists of three 90-minute sessions and one abstract session. Summary details can be found below or visit our online itinerary planner.

For detailed information about these sessions, visit our helpful online itinerary planner to view: T ype ‘AF Summit Update’ in the Search box.

Many of the internationally renowned faculty (see below) have returned to participate in the AF Summit Update, including: Douglas L. Packer, MD, FHRS; Hugh Calkins, MD, FHRS; Carlo Pappone, MD, Ph.D.; Andrea Natale, MD, FHRS; Warren M. Jackman, MD, FHRS; Patrick T. Ellinor, MD, Ph.D.; Francis E. Marchlinski, MD; Samuel J. Asirvatham, MD; Vivek Y. Reddy, MD and many more!

The AF Summit Update will take place in Moscone Center: Thursday sessions in Room 103, Friday in Room 220. Session titles:

Thursday, May 15

• AF Summit Update I: AF Mechanisms and Mechanism Based Therapy,
  8:00 – 10:30 a.m.
• AF Summit Update II: AF Ablation: Clinical Outcomes,
  10:30 a.m. – 1:30 p.m. 
• AF Summit Update III: Highest Ranking AF Abstracts,
  1:30 – 4:30p.m.
• AF Summit Update IV: New Generation Imaging for Ablative Interventions,
  4:30 – 6:00 p.m.

Friday, May 16

• AF Summit: 365 Days Later,
  4:30 p.m. 

This year there will also be an AF Ablation Live Case Session, held on Friday, May 16 at 1:30 p.m. in Room 103. See Live Complex Ablations Cases for more information.

The AF Summit Update is supported by an
unrestricted educational grant from St. Jude Medical

AF Summit Update (Thursday, May 15 — Room 103)

AF Summit Update I: AF Mechanisms and Mechanism Based Therapy
Chairs:
Penelope Boyden
Benjamin Scherlag

• Update on Cellular and Neural Mechanisms of AF
  Omer Berenfeld
• Matching Mechanisms to Therapy: A Panel Discussion
  Moderator: Penelope Boyden
  Panelists:
  Peng-Sheng Chen
  Stanley Nattel
  Nicholas Peters
  Albert Waldo
  Douglas Zipes
  
• Molecular and Cellular Therapies for AF: Biologic Alternatives to Toxic Drugs and Destructive Energy
  T. Jared Bunch
  
• Heart Rhythm Society Founders' Lectureship — AF In The Next Half Decade: What Will Matter Most
  A.Camm
• Forging the Critical Links Between Genotype and Clinical Presentations: Translations into Tomorrow's Therapy
  Patrick Ellinor

AF Summit Update II: AF Ablation: Clinical Outcomes
Chair: Johannes Brachman

• The Most Important Developments of the Past 6 Months; Most Important Trends for the Next Year
  Moderator: Francis Marchlinski
  Panelists:
  David Callans
  Riccardo Cappato
  Pierre Jais
  Andrea Natale
  Carlo Pappone
  Win-Kuang Shen
• Update on Next Years' AF Ablation
  Michel Haissaguerre
• Update on Ablation Targeting Ganglion Plexes: A Part of the Total Ablative Arsenal?
  Warren Jackman
• Balloon-based and Other Novel Alternative Ablation Strategies for AF
  Karl-Heinz Kuck
• Sinus Rhythm Nests vs. Complex Fractionated and High Frequency EGM: What Do They Mean?
  Andrea Natale

AF Summit Update III: Highest Ranking AF Abstracts
Chairs:
David Haines
Changsheng Ma

• Quantitative Measurement and Three Dimensional Visualization of Scar Formation Following Pulmonary Vein Isolation for Atrial Fibrillation
  Marcos Daccarett
• Does the Ablation of Complex Fractionated Electrograms Add to the Success of Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation? Long-term follow up of a prospective randomized study
  Isabel Deisenhofer
• Antiarrhythmic Effect of Statin in Atrial Fibrillation is not Dose Dependent nor Related to LDL Decrease : A Meta-analysis of Randomized Controlled Trials
  Laurent Fauchier
• MEDAFI-Trial (Microembolization During Ablation of Atrial Fibrillation): Comparison of Pulmonary Vein Isolation using Cryo Balloon Technique Versus Radiofrequency energy
  Malte Kuniss
• The Effect and Safety of the Anti-thrombotic Therapies in Patients with Atrial Fibrillation of CHADS² Score 1
  Jae-Seok Park
• Long-Term Quality of Life After Ablation for Atrial Fibrillation: Symptom Relief or Placebo Effect?
  Anita Wokhlu

AF Summit Update IV: New Generation Imaging for Ablative Interventions
Chairs:
Hugh Calkins
Changsheng Ma

• Outcomes of Interventional EP: Is There Solid Support for High Tech Mapping and Ablation? What Else is Needed?
  Moderator: Hugh Calkins
  Panelists:
  Samuel Asirvatham
  Shih-Ann Chen
  D. Wyn Davies
  David Haines
  Gerhard Hindricks
  
• Multimodality CT/MR/Rotational Angiography-based Mapping Revolution: Are There Data to Support It?
  Timm-Michael Dickfeld
• 3D Ultrasound Guided Ablation: From Imaging to Mapping
  Douglas Packer
• Integrated Image-Guided, Robotic Directed Technologies
  Vivek Reddy
• What is in an Electrogram: New Electrogram Content-Based Mapping
  David Wilber

AF Summit: 365 Days Later (Friday, May 16 — Room 220)
Chairs:
Douglas Beinborn
Deborah Moyer

• Medical Management vs. ABL: Is the Jury Still Out?
  Joshua Cooper
• Managing Patients Post-MAZE: Special Considerations for Allieds
  Zayd Eldadah
• Do Targeted AF Clinics Improve Patient Care and Satisfaction?
  Liza Prudente